ReviewCurrent opinion in rheumatology2020

The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis.

Thais Ribeiro Peclat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.